Smoking and total mortality
46 results
1 - 46
Smoking and total mortality 
Exercise for people with high cardiovascular risk: Cochrane systematic review- Kidney cancer
Similar long-term morbidity and mortality with human insulin and analogue insulins- High-end normal bilirubin level associated with reduced risk of lung disease and mortality
- Screening for lung cancer
- General health checks in adults for reducing morbidity and mortality from disease
- Low HbA1C, BP, and cholesterol in elderly patients with DMT2 associated with high mortality
- Nut consumption associated with a lower risk of many bad things
- Increased daily steps associated with reduced all-cause mortality
- Multiple risk factor interventions for primary prevention of coronary heart disease
- No association between SSRI use in pregnancy and risk of stillbirth or infant mortality
- Extremely high HDL cholesterol associated with increased mortality in men and women
- Ischaemic stroke and myocardial infarction risk with combined oral contraceptives
- Beta-blockers associated with improved morbidity/mortality in COPD patients
- Interventions for recruiting smokers into cessation programmes
- Multiple risk factor interventions for primary prevention of cardiovascular disease in low‐ and middle‐income countries
- The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
- Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality
- Antidepressants for smoking cessation
- Antibiotic use associated with a risk of cardiovascular disease in adult women
- Azithromycin of questionable benefit given daily for COPD
- Service organisation for the secondary prevention of ischaemic heart disease in primary care
- Screening for lung cancer
- Association of systolic blood pressure and complications of type 2 diabetes
- Antiplatelet agents for intermittent claudication: Cochrane systematic review
- Standard‐ versus extended‐duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
- Choice of antihypertensive drug in the diabetic patient from prognostic point of view
- Multimorbidity
- Varenicline and bupropion and suicidal behaviour
- Association of glycaemic control and complications of type 2 diabetes
- Self‐management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease
- Prostanoids for critical limb ischaemia
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- Targeted mass media interventions promoting healthy behaviours to reduce risk of non‐communicable diseases in adult, ethnic minorities
- Effects of a gluten‐reduced or gluten‐free diet for the primary prevention of cardiovascular disease
- Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
- Tiotropium versus long‐acting beta‐agonists for stable chronic obstructive pulmonary disease
- Aclidinium bromide for stable chronic obstructive pulmonary disease
- Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic peripheral arterial disease
- Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)
- Maternal obesity and infant outcomes
- Aortic aneurysm and dissection